Patients Diagnosed With CancerAROMA-FOOTBATHNCT07721168
THE EFFECT OF AROMATHERAPY FOOT BATHS ON CANCER PATIENTS
A study testing Aromatherapy in people with Patients Diagnosed With Cancer, run by Ankara Yildirim Beyazıt University.
Trial summary
The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question[s] it aims to answer are: Is an aromatherapy foot bath effective in reducing pain in cancer patients? Is an aromatherapy foot bath effective… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Patients Diagnosed With Cancer
- What is being tested?
- Aromatherapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2026to 1 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients over 18 years of age,
- Conscious (Glasgow coma scale: 15 points)
- No diagnosis of mental illness
- No respiratory distress
- No diagnosis of respiratory system disorder
- Patients who agree to participate in the study
Who cannot join
- Patients under 18 years of age,
- Patients with a Glasgow Coma Scale score below 15 points,
- Patients with a diagnosis of mental illness,
- Patients with respiratory distress,
- Patients with a diagnosis of respiratory system disease,
- Patients with hemiplegia or paraplegia,
- Patients who refused to participate in the study.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: THE EFFECT OF AROMATHERAPY FOOT BATHS ON PAIN, SLEEP QUALITY, AND FATIGUE IN CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL
The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question[s] it aims to answer are:
- Is an aromatherapy foot bath effective in reducing pain in cancer patients?
- Is an aromatherapy foot bath effective in improving sleep quality in cancer patients?
- Is an aromatherapy foot bath effective in reducing fatigue in cancer patients? The experimental group will receive a total of 5 sessions of aromatherapy foot baths, each lasting 20 minutes per day for 5 days, administered by the researcher. The control group will receive only routine care without any treatment. Before and after all treatments are completed, participants will be given and asked to complete the Hirai Cancer Fatigue Scale, the Pittsburgh Sleep Quality Index (PSQI), and the Numerical Pain Scale. The pain, fatigue, and sleep quality scores of the experimental and control groups will then be compared.
- Conditions
- Patients Diagnosed With Cancer
- Being tested
- Aromatherapy
- Keywords
- Aromatherapy, Foot bath, Pain, Fatigue, Sleep quality
- Medical subject headings
- Pain, Fatigue, Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AromatherapyOther
The experimental group will receive a foot bath treatment containing aromatherapy for 5 days administered by the researcher. A foot bath device will be used. Lavender essential oil will be added to the water as aromatherapy. Then, the researcher will administer a foot bath to the patient using this water.
| Study group | Role | What they receive |
|---|---|---|
| Aromatherapy Group | Experimental | The experimental group will receive a foot bath treatment containing aromatherapy. Receives: Other: Aromatherapy |
| Standard Care Group | No intervention | The control group will not receive a foot bath containing aromatherapy. They will only receive the routine care provided in the service. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hirai Cancer Fatigue Scale
The scale has a minimum score of 15 and a maximum score of 75. Higher scores indicate increased fatigue, while lower scores indicate decreased fatigue.
Measured: Baseline and day 5
Numerical Pain Scale
Participants will be asked to rate the intensity of their pain on a scale of 0 (no pain) to 10 (most severe pain). A higher score indicates increasing pain.
Measured: Baseline and day 5
Pittsburgh Sleep Quality Index
The total score ranges from 0 to 21. A total score higher than 5 indicates poor sleep quality.
Measured: Baseline and day 5
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2026
- Study start1 Aug 2026 (estimated)
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Patients Diagnosed With CancerStudies of the same condition, open and under way.
- More trials run by Ankara Yildirim Beyazıt UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ankara Yildirim Beyazıt University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Semra Gündoğdu, Ankara Yildirim Beyazıt University
- Investigators
- Semra Gündoğdu, Principal investigator, Ankara Yildirim Beyazıt UniversityErdal Ceylan, Study director, Ankara Yildirim Beyazıt UniversityAhmet Özgen Yıldırım, Study chair, Ankara Etlik City Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07721168
- Sponsor's protocol ID
- 2026-02/77
- Acronym
- AROMA-FOOTBATH
- Status last verified
- Jul 2026
- First submitted
- 14 Jul 2026
- Last updated
- 22 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- THE EFFECT OF AROMATHERAPY FOOT BATHS ON PAIN, SLEEP QUALITY, AND FATIGUE IN CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL
- ClinicalTrials.gov ID
- NCT07721168
- Acronym / sponsor ID
- AROMA-FOOTBATH / 2026-02/77
- Conditions
- Patients Diagnosed With Cancer
- Keywords
- Aromatherapy, Foot bath, Pain, Fatigue, Sleep quality
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Ankara Yildirim Beyazıt UniversityUniversity, hospital or other
- Study start
- 1 Aug 2026 (estimated)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 22 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question[s] it aims to answer are:
- Is an aromatherapy foot bath effective in reducing pain in cancer patients?
- Is an aromatherapy foot bath effective in improving sleep quality in cancer patients?
- Is an aromatherapy foot bath effective in reducing fatigue in cancer patients? The experimental group will receive a total of 5 sessions of aromatherapy foot baths, each lasting 20 minutes per day for 5 days, administered by the researcher. The control group will receive only routine care without any treatment. Before and after all treatments are completed, participants will be given and asked to complete the Hirai Cancer Fatigue Scale, the Pittsburgh Sleep Quality Index (PSQI), and the Numerical Pain Scale. The pain, fatigue, and sleep quality scores of the experimental and control groups will then be compared.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Aromatherapy Group | Experimental | Other: AromatherapyThe experimental group will receive a foot bath treatment containing aromatherapy. |
| Standard Care Group | No intervention | –The control group will not receive a foot bath containing aromatherapy. They will only receive the routine care provided in the service. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Patients over 18 years of age,
- Conscious (Glasgow coma scale: 15 points)
- No diagnosis of mental illness
- No respiratory distress
- No diagnosis of respiratory system disorder
Key exclusion criteria (7 listed)
- Patients under 18 years of age,
- Patients with a Glasgow Coma Scale score below 15 points,
- Patients with a diagnosis of mental illness,
- Patients with respiratory distress,
- Patients with a diagnosis of respiratory system disease,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AromatherapyThe experimental group will receive a foot bath treatment containing aromatherapy for 5 days administered by the researcher. A foot bath device will be used. Lavender essential oil will be added to the water as aromatherapy. Then, the researcher will administer a foot bath to the patient using this water. | Other | Aromatherapy Group |
Primary outcome
Hirai Cancer Fatigue Scale
Time frame: Baseline and day 5
The scale has a minimum score of 15 and a maximum score of 75. Higher scores indicate increased fatigue, while lower scores indicate decreased fatigue.
Numerical Pain Scale
Time frame: Baseline and day 5
Participants will be asked to rate the intensity of their pain on a scale of 0 (no pain) to 10 (most severe pain). A higher score indicates increasing pain.
Pittsburgh Sleep Quality Index
Time frame: Baseline and day 5
The total score ranges from 0 to 21. A total score higher than 5 indicates poor sleep quality.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Patients Diagnosed With Cancer
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Active, not recruitingPhase 1/2
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Multiple Myeloma
RecruitingPhase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Not yet recruitingPhase 2
QLS4131 Plus Isa-V-CHOP in Newly Diagnosed, HIV-Negative PBL: A Single-Center, Single-Arm, Phase II Study
Plasmablastic Lymphoma
RecruitingPhase 1
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Semra Gündoğdu principal investigator
Ankara Yildirim Beyazıt University
Erdal Ceylan study director
Ankara Yildirim Beyazıt University
Ahmet Özgen Yıldırım study chair
Ankara Etlik City Hospital
Questions about this trial
What is this clinical trial studying?
A study testing Aromatherapy in people with Patients Diagnosed With Cancer, run by Ankara Yildirim Beyazıt University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Erdal Ceylan (+905362323599, erdalceylan@aybu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hirai Cancer Fatigue Scale (time frame: Baseline and day 5). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.